Following confirmation of NI, subsequent testing for superiority was performed, and for all three trials superiority was concluded for both doses of SEM versus SIT, EXE, and IG for change from baseline in A1C
Q4h would be every four hours
Tuesday: The Guidance Shock On February 3rd, Novo Nordisk pre-released its 2026 outlook and it was ugly
Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer
Clear, medically reviewed answers about semaglutide for Miami members how the online program works, branded vs compounded, safety, cost, and eligibility
IGF-1 Monitoring and Biological Implications